Berendine J. Ebbink

Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain

Berendine J. Ebbink, Esther Poelman, Femke K. Aarsen et al. · Developmental Medicine & Child Neurology · 2018 · 108 citations · Full text

Medicine, Neurology, Neuroscience +17

Facial‐muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy

Carin M. Van Gelder, Carine I. van Capelle, Berendine J. Ebbink et al. · Journal of Inherited Metabolic Disease · 2011 · 89 citations · Full text

Health Professions, Neurology, Pediatrics +16

Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy

Berendine J. Ebbink, Femke K. Aarsen, Carin M. Van Gelder et al. · Neurology · 2012 · 74 citations

Medicine, Neurology, Pediatrics +17

Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure

Johanna H. van der Lee, J. Morton, Heather Adams et al. · Molecular Genetics and Metabolism · 2017 · 47 citations · Full text

Medicine, Neurology, Pediatrics +17

Cognitive decline in classic infantile Pompe disease: An underacknowledged challenge

Berendine J. Ebbink, Esther Poelman, Iris Plug et al. · Neurology · 2016 · 45 citations

Life Sciences, Neurology, Pediatrics +17